줄기세포 치료 시장 규모, 점유율, 성장 분석 : 치료법별, 종류별, 공급원별, 투여 경로별, 기술별, 용도별, 지역별 - 업계 예측(2026-2033년)

Global Stem Cell Therapy market size was valued at USD 369.62 Million in 2024 and is poised to grow from USD 438.74 Million in 2025 to USD 1729.07 Million by 2033, growing at a CAGR of 18.7% in the forecast period (2026-2033).

The global stem cell therapy market is experiencing notable expansion, propelled by the rising incidence of chronic diseases and the adoption of stem cell-based treatments as effective outcome-oriented solutions. This market benefits from increasing regulatory support and a growing consumer demand for regenerative medicine. Notably, cell therapies utilizing Mesenchymal Stem Cells (MSCs) and Induced Pluripotent Stem Cells (iPS) are becoming prominent, with applications emerging across various therapeutic fields such as neurology, cardiology, and musculoskeletal disorders. Nonetheless, significant challenges persist, including the high upfront costs associated with research, clinical trials, and regulatory approvals, alongside technical difficulties in commercialization, which collectively act as substantial barriers to market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Therapy Market Segments Analysis

The global stem cell therapy market is segmented into type, therapy, source, route of administration, technology, application, end user, and region. By type, the market is classified into Totipotent Stem Cells, Multipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells, Others. Depending on therapy, it is divided into Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy. According to source, the market is categorized into Adult Stem Cells, Embryonic Stem Cells, Mesenchymal Stem Cells (MSCs), and Induced Pluripotent Stem Cells (iPS). Depending on route of administration, it is divided into Intravenous (IV) Infusion, Intraarticular Injection, Intrathecal Injection, Intradermal Injection, Others. By technology, the market is classified into Cell Acquisition (Bone Marrow Harvest, Umbilical Blood Cord, Apheresis), Cell Production (Therapeutic Cloning, In-vitro Fertilization, Cell Culture, Isolation), Cryopreservation, Expansion and Sub-Culture. According to application, the market is categorized into Musculoskeletal Disorders, Wounds & Surgeries, Inflammatory & Autoimmune Diseases, Cardiovascular Diseases, Neurological Disorders, and Others. By end user, the market is classified into Hospitals, Specialty Clinics, Academic & Research Institutes, and Others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Driver of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is significantly driven by financial support from governmental bodies and favorable regulatory frameworks, which create an encouraging environment for research and development in the field. This support has fostered heightened research initiatives and funding opportunities for cellular studies, largely due to the pressing demand for innovative and effective treatment solutions for a variety of conditions, including autoimmune, neurological, and cardiovascular diseases. Such investments in developing infrastructure, like biomanufacturing facilities, further bolster the growth of stem cell therapies, enhancing both the capabilities and resources available for advancing this promising area of medicine.

Restraints in the Global Stem Cell Therapy Market

The global stem cell therapy market faces significant challenges due to ethical concerns surrounding the use of embryonic stem cells, primarily derived from human embryos. This raises profound moral questions related to the potential termination of human life, which complicates the landscape of stem cell research and development. Additionally, the regulatory environment governing stem cell therapies is inconsistent across different regions, influenced by varying cultural and societal attitudes. Such disparities not only stymie innovation but also create uncertainty for researchers and investors, ultimately limiting the progress and commercialization of stem cell therapies in the marketplace.

Market Trends of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is experiencing a significant trend towards innovation and the development of advanced therapeutics, prompting companies to seek specialized talent to drive research and application. As breakthroughs in regenerative medicine gain momentum, the demand for skilled professionals with expertise in genetic engineering, cellular biology, and clinical trial management is intensifying. This trend reflects the growing investment in stem cell research and the increasing collaboration between biotech firms, academic institutions, and healthcare providers. Consequently, the market is positioned for robust growth, fueled by advancements that promise to transform treatment paradigms across various medical conditions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Study Analysis
• Patent Analysis

Global Stem Cell Therapy Market Size by Type & CAGR (2026-2033)

• Market Overview
• Totipotent Stem Cells
• Multipotent Stem Cells
• Pluripotent Stem Cells
• Unipotent Stem Cells
• Others

Global Stem Cell Therapy Market Size by Therapy & CAGR (2026-2033)

• Market Overview
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy

Global Stem Cell Therapy Market Size by Source & CAGR (2026-2033)

• Market Overview
• Adult Stem Cells
• Embryonic Stem Cells
• Mesenchymal Stem Cells (MSCs)
• Induced Pluripotent Stem Cells (iPS)

Global Stem Cell Therapy Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Intravenous (IV) Infusion
• Intraarticular Injection
• Intrathecal Injection
• Intradermal Injection
• Others

Global Stem Cell Therapy Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Cell Acquisition
  • Bone Marrow Harvest
  • Umbilical Blood Cord
  • Apheresis
• Cell Production
  • Therapeutic Cloning
  • In-vitro Fertilization
  • Cell Culture
  • Isolation
• Cryopreservation
• Expansion and Sub-Culture

Global Stem Cell Therapy Market Size by Application & CAGR (2026-2033)

• Market Overview
• Musculoskeletal Disorders
• Wounds & Surgeries
• Inflammatory & Autoimmune Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Others

Global Stem Cell Therapy Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Academic & Research Institutes
• Others

Global Stem Cell Therapy Market Size & CAGR (2026-2033)

• North America (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
  • US
  • Canada
• Europe (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medipost Co. Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JCR Pharmaceuticals Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anterogen Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corestem, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmicell Co., Ltd (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Holostem SRL (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stempeutics Research Pvt Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regrow Biosciences Pvt Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healios KK (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioRestorative Therapies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pluri Inc. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BrainStorm Cell Inc (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ayrmid Limited (Gamida Cell) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertex Pharmaceuticals (ViaCyte, Inc.) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kangstem Biotech Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations